Navigation Links
Sponsor of Drug Bill Rejected by CA Senate Today Changed Its Name After Privacy Violations
Date:5/22/2008

SANTA MONICA, Calif., May 22 /PRNewswire-USNewswire/ -- The California Senate rejected a bill today sponsored by a drug marketing firm that was forced to change its name after privacy violations. See Washington Post coverage below.

The bill, SB 1096 (Calderon), which was granted a second chance to pass the Senate and will be voted on again next week, would create a loophole in existing law which bars the sharing of private medical information -- including a patient's illnesses and prescribed medications -- without a patient's prior consent.

"The California Constitution protects the privacy of all Californians. At a minimum, patients must be asked and give consent before their medical records are traded or sold. As personal information -- medical, financial and domestic -- becomes an increasingly available and valuable commodity for the corporations that buy and sell it, consumers are more vulnerable to unscrupulous marketers, identity thieves and corrupt corporations," said Jerry Flanagan, Health Care Policy Director for Consumer Watchdog. "We urge the Senate to continue to oppose this measure unless it is amended to require a patient's informed consent prior to the transfer of private medical information."

In the last 2 years, the bill author, Senator Ronald Calderon, has received at least $21,690 from drug companies and others that will benefit from the legislation.

The bill would allow companies like Adheris, the bill sponsor, to access patients' prescription drug purchases, putatively only for the purpose of communicating with patients to increase "adherence" to the scheduled regimen. The bill is premised on the idea that mailed reminders will help ensure that patients take their medications. The bill sponsor provides no evidence to support the claim. Further, if in fact a reminder to take medication was the goal of the bill, the pharmacy itself could send the reminder without necessitating the transfer of private medical data to a third-party business.

"The bill sponsor is a marketing company employed by drug manufacturers to increase the sales of prescription drugs and has no place in 'informing' patients about their illness without their prior consent. This seemingly benign 'service' violates a patient's right to control his or her personal medical information," said Flanagan.

SB 1096 raises the following concerns:

1. There is no way in many instances for Adheris to know exactly why a medication has been prescribed or how a doctor expects it to be taken.

2. Adheris' advice about how long a medication should be taken may conflict with that of the physician who actually knows the patient, and who may wish to stop the medication or switch to a different medication. If such conflicts occur for even a short time, they may reduce patients' confidence in their doctor.

3. The patient's doctor may want him or her to report all significant side effects (particularly among the elderly, weak or immune-compromised), not just those that Adheris may describe as serious or life-threatening.

4. Further, medical records are often coded with a patient's Social Security number. Information aggregators that get access to medical records could use the Social Security number to combine medical information with a wide range of information already available, including credit information and lists of credit card purchases and bank account balances. The resulting data file would be immensely valuable to companies looking to market products or, in the case of insurers or even mortgage lenders, deny a policy or loan based on combined health and financial data. The digital dossier, maintained without direct government oversight, would also be an attractive target for hackers and identity thieves.

Washington Post coverage of Adheris' name change and privacy violations:

After Privacy Flap, a New Name; Other Changes at Prescription-Reminder Firm

Less Clear: http://www.consumerwatchdog.org/patients/articles/?storyId=20325

Ultimately, a Healthy Decision At Giant and CVS Pharmacy: http://www.consumerwatchdog.org/patients/articles/?storyId=20326

CVS Also Cuts Ties To Marketing Service; Like Giant, Firm Cites Privacy on

Prescriptions: http://www.consumerwatchdog.org/patients/articles/?storyId=20327

EDITORIAL - When Private Means Private:http://www.consumerwatchdog.org/patients/articles/?storyId=20328

Giant Food Stops Sharing Customer Data; Prescription-Marketing Plan Drew Complaints: http://www.consumerwatchdog.org/patients/articles/?storyId=20329

Prescription Sales, Privacy Fears; CVS, Giant Share Customer Records With Drug Marketing Firm: http://www.consumerwatchdog.org/patients/articles/?storyId=20331


'/>"/>
SOURCE Consumer Watchdog
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Aflac to be Primary Sponsor of Carl Edwards and the No. 99 Ford Fusion
2. C5 Medical Werks Joins in Sponsoring SpineWeek 2008 in Geneva, Switzerland
3. UPMC for Life is Pennsylvania Sponsor for National Senior Health & Fitness Day
4. Duane Reade Announces Proud Sponsorship of AIDS Walk New York
5. West Coast Bank Sponsors Reach the Bridge Run to Benefit the American Lung Association of Oregon
6. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
7. Aflac Announces Title Sponsorship of Outdoor Games
8. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
9. Target Data Research Becomes the Largest Sponsor for the Annual 2008 Steppin Forward Benefit
10. Integrium Introduces Its Integrium Clinical Excellence (ICE) Methodology to Assure Consistent Delivery of Sponsor Clinical Trials
11. West Coast Bank Sponsors Reach the Beach Cycling Fundraiser to Support the American Lung Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
(Date:6/24/2016)... Mass. and SAN CLEMENTE, Calif. , ... California -based mobile pulmonary function testing company, is now able ... PFT devices developed by ndd Medical Technologies , Inc. ... testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® ... , can get any needed testing done in the comfort ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: